Market Overview:

The global dialyzer market reached a value of US$ 3.29 Billion in 2021. Looking forward, IMARC Group expects the market to reach a value of US$ 4.54 Billion by 2027, exhibiting a growth rate (CAGR) of 5.20% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic. These insights are included in the report as a major market contributor.

A dialyzer, also known as an artificial kidney, is an apparatus manufactured using a thin and fibrous material to form a semipermeable membrane, which allows smaller particles and liquids to pass through. It is a cost-effective solution that removes excess fluids and wastes from the blood when kidneys are unable to function properly and prevents accumulation of salt and poisoning. It offers several advantages, such as less waste disposal, minimizing environmental impact, decreasing the frequency of first use syndrome, and improving biocompatibility. As a result, it finds extensive applications in in-center dialysis and home dialysis across the globe.

Dialyzer Market Trends:

At present, there is a rise in the prevalence of diabetes, hypertension, heart disease, and end-stage renal diseases (ESRD) among individuals. This, along with the growing geriatric population around the world, represents one of the key factors driving the market. Moreover, the increasing funding on improving dialysis products and services by governments of several countries is propelling the growth of the market. In addition, the shortage of kidneys for transplantation across the globe is offering lucrative growth opportunities to key market players. Besides this, the availability of trained medical staff in dialysis centers that provide better services to the patient is positively influencing the market. Additionally, the rising utilization of novel products to treat chronic kidney conditions is catalyzing the demand for dialyzers worldwide. Apart from this, the higher efficiency of high-flux dialyzers to remove large size toxin molecules during the hemodialysis is bolstering the growth of the market. Other growth-inducing factors are the expanding healthcare industry, rising medical tourism, increasing reimbursement policies and technological advancements in the product production process.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global dialyzer market, along with forecasts at the global, regional and country level from 2022-2027. Our report has categorized the market based on type, usage type and end user.

Breakup by Type:

• High-Flux Dialyzer
• Low-Flux Dialyzer
   

Breakup by Usage Type:

• Disposable
• Reusable
   

Breakup by End User:

• Hospitals and Clinics
• Ambulatory Surgical Centers
• Home Care Settings
• Dialysis Centers
   

Breakup by Region:

• North America
  • United States
  • Canada
• Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
• Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
• Latin America
  • Brazil
  • Mexico
  • Others
• Middle East and Africa
   

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Asahi Kasei Corporation, B. Braun Melsungen AG, Baxter International Inc., Browndove Healthcare (P) Ltd., Cantel Medical Corporation (Steris plc), Dialife SA, Farmasol, Fresenius Medical Care AG & Co. KGaA, Medica S.p.A., Medtronic plc, Nikkiso Co. Ltd., Nipro Corporation, Shandong Weigao Group Medical Polymer Co. Ltd. and Toray Industries Inc.

Report Coverage: